Precision BioSciences, Inc. (DTIL) Financials

DTIL Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 164.3 million 135.3 million
2023-06-30 181.7 million 147.7 million
2023-03-31 204.5 million 164.3 million
2022-12-31 238.2 million 177.7 million

DTIL Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -23.5 million 3.1 million
2023-06-30 -22.3 million 3.9 million
2023-03-31 -32.2 million 4.1 million
2022-12-31 -22.5 million 4.5 million

DTIL Net Income

No data available :(

DTIL Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 122.2 million - 1.5 million
2023-06-30 137.8 million - 5.7 million
2023-03-31 158.1 million 22.3 million 4.3 million
2022-12-31 189.6 million 22.2 million 4.8 million

DTIL Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 115.2 million
2023-06-30 114.1 million
2023-03-31 111.3 million
2022-12-31 111.0 million

DTIL Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 436000 15.9 million 9.6 million -
2023-06-30 1.1 million 21.9 million 9.8 million -
2023-03-31 721000 22.2 million 11.1 million -
2022-12-31 632000 21.1 million 10.1 million -

DTIL Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 13.1 million 2.0 million
2023-06-30 19.8 million 2.4 million
2023-03-31 8.8 million 2.3 million
2022-12-31 10.6 million 2.3 million

DTIL

Price: $11.17

52 week price:
8.25
28.44

Earnings Per Share: -332.12 USD

P/E Ratio: -13.94

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 459600

Market Capitalization: 94.0 million

Links: